About us
Repair Biotechnologies is a preclinical biotechnology company focused on developing drugs for cholesterol and aging-related diseases. Our first-in-class Cholesterol Degrading Platform (CDP) technology is aimed at reversing atherosclerosis, familial hypercholesterolemias, and other conditions in which excess or modified cholesterol drives pathology.
- Website
-
https://www.repairbiotechnologies.com/
External link for Repair Biotechnologies
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Syracuse, New York
- Type
- Privately Held
- Founded
- 2018
Locations
-
Primary
Get directions
841 E Fayette St
Syracuse, New York 13210, US
Employees at Repair Biotechnologies
-
Kufre Inyang, Ph.D.
Scientist III at Repair Biotechnologies
-
Bill Cherman
Co-founder and CEO: Bay Area Times (250K subscribers) | Seed investor: Ethereum, HEX, STEPN, Dante Labs, Repair Bio
-
Jing Li, PhD
Biochemistry and Molecular Biology
-
Brendan Hickey B.S., PharmD.
Associate Scientist at Repair Biotechnologies